Viking Therapeutics, Inc. (NASDAQ:VKTX) Forecasted to Post Q1 2024 Earnings of ($0.25) Per Share
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Equities researchers at HC Wainwright issued their Q1 2024 EPS estimates for shares of Viking Therapeutics in a research report issued on Thursday, February 8th. HC Wainwright analyst J. Pantginis anticipates that the biotechnology company will post earnings per share of ($0.25) for the quarter. The consensus […]
More Stories
Ukraine, Russia and Europe: Why the Future of European Security Is at a Turning Point
European diplomacy faces important questions about security, peace and international cooperation. The war in Ukraine continues to shape Europe's political...
COP31: Can World Leaders Turn Climate Promises into Real Action?
Renewable energy investment is central to the international effort to reduce greenhouse gas emissions. Climate change has become one of...
Who Controls the Machines? The Global Debate Over AI-Powered Autonomous Weapons
Global Affairs and Technology | 16 November 2026 Artificial intelligence is creating new questions about human control, responsibility and the...
How Artificial Intelligence Is Reshaping Global Trade and Creating New Winners
Artificial intelligence is transforming semiconductor manufacturing, international investment and global trade. Image: Unsplash International Business and Technology Artificial intelligence is becoming...
Developing Countries Face a Record Debt Burden as Borrowing Costs Remain High
Infrastructure investment and international financing play a critical role in developing economies. Image: Unsplash International Finance Developing economies are facing a...
The Global Economy Is Resilient, but the Benefits Are Becoming Increasingly Uneven
Global trade and international supply chains remain important drivers of economic activity. Image: Unsplash Economic Analysis The global economy has...
